The expiration of ACA tax credits could drive up premiums across marketplace and commercial insurance plans, a Cigna executive warned.

Bayer’s Lynkuet, approved for treating moderate-to-severe vasomotor symptoms of menopause, targets two receptors key to ...

Phony bank account change requests aren’t just another check box on a fraud prevention list – they’re one of the most immediate and dangerous threats facing healthcare AP teams today.

As always, this year's HLTH conference brought a slew of announcements — from product launches to funding rounds to new partnerships. This list features short summaries for seven of the conference’s ...

CMS’ new $50 billion rural health fund seeks to help rural providers sustain care in their communities over the next five years. However, experts believe the program will not be enough to stabilize ...

Healthcare’s relationships with AI and digital transformation are a mix of excitement and uncertainty. Even as hospitals begin to see returns on their technology deployments, leaders acknowledge that ...

A Bayer drug the company frames as key to growing its cardiovascular portfolio has expanded its FDA approval to a type of heart failure, a new indication that keeps this pill on the path to achieving ...

An experimental Organon drug for alleviating pain caused by endometriosis fell short of the main goal of a mid-stage clinical trial, leading the company to discontinue development of this product ...

Update: This case was resolved on Sunday evening via a settlement, so the trial never occurred. The attorneys representing Hernandez told MedCity News that he categorically denies the allegations.

Aside from Humana and Kaiser Permanente Ventures, Omada Health has scored yet another insurer investor: Cigna. Omada, which has a built a digital platform to prevent prediabetics from becoming ...